5/14
08:07 am
rphm
Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock.
Medium
Report
Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock.